Profile of immunological biomarkers in Behcet’s syndrome: a large-scale single-center real-world study
Clinical and Experimental Medicine · 2024
DOI: 10.1007/s10238-024-01462-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2024. Verfasst von Jiachen Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, 100044, China. Hauptthemen laut MEDLINE: Behcet Syndrome, Biomarkers, Autoantibodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Behcet's syndrome (BS) is a vasculitis characterized by immune dysregulation. Biomarkers are valuable for assessing clinically atypical pathogenesis. We aimed to investigate the distribution of different biomarkers and their effects on the clinical features of patients with BS in a large-scale, real-world study. This is a retrospective, single-center study. In total, 502 patients diagnosed with BS were enrolled in this study. We analyzed the clinical features of this cohort and divided patients' symptoms into six categories, including mucocutaneous, articular, neurological, gastrointestinal, vascular, and ocular involvements. HLA-B51 cells, autoantibodies, and subsets of immune cells from the patients were tested. Pearson's correlation, Wilcoxon rank sum test and multivariate logistic regression were used for data analysis. Various autoantibodies were detected in the serum of 40.8% of patients with BS. The positivity rate of anti-endothelial cell antibodies (AECA) was the highest among autoantibodies and was found in 23.5% (118/502) of patients with BS. The positivity rate of HLA-B51 in patients with BS was 27.1%. Tumor necrosis factor (TNF)-α, IL-2, and IL-4 producing CD4+ T cells were positively correlated with the gastrointestinal BS. Increased IL-4+CD4+ T cell was a risk factor for gastrointestinal BS (P = 0.006, Overall rate [OR] = 2.491, 95% Confidence interval [CI]: [1.317, 5.100]). Various autoantibodies can be detected in patients with BS. HLA-B51 and AECA are the most common biomarkers. Increased IL-4+ CD4+ T cell was a risk factor for gastrointestinal involvement in BS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, 100044, China.
- Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, 100044, China.
- Yulin Red Cross Hospital, Yulin, 537000, Guangxi Zhuang Autonomous Region, China.
- Beijing Friendship Pinggu Hospital of Capital Medical University, Beijing, 101200, China.
- Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, 100044, China. li99@bjmu.edu.cn.
- Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, 100044, China. li99@bjmu.edu.cn.
Zitieren
APA
Li, J., Sun, F., Li, Y., Zhao, J., Jia, R., Wang, H., Xiang, X., Sun, X., Chen, C., Xu, H., Li, Z., & Liu, T. (2024). Profile of immunological biomarkers in Behcet’s syndrome: a large-scale single-center real-world study. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01462-5
Vancouver
Li J, Sun F, Li Y, Zhao J, Jia R, Wang H, et al. Profile of immunological biomarkers in Behcet’s syndrome: a large-scale single-center real-world study. Clinical and Experimental Medicine. 2024. doi:10.1007/s10238-024-01462-5
BibTeX
@article{Li2024,
author = {Li, Jiachen and Sun, Feng and Li, Yingni and Zhao, Jing and Jia, Rulin and Wang, Hongyan and Xiang, Xiaohong and Sun, Xiaolin and Chen, Chengbin and Xu, Haixin and Li, Zhanguo and Liu, Tian},
title = {Profile of immunological biomarkers in Behcet’s syndrome: a large-scale single-center real-world study},
journal = {Clinical and Experimental Medicine},
year = {2024},
doi = {10.1007/s10238-024-01462-5}
}
EUVIMED